{
  "data": {
    "id": "org_ministry-of-commerce-of-china",
    "slug": "ministry-of-commerce-of-china",
    "name": "Ministry of Commerce of China",
    "short_name": "MOFCOM",
    "type": "government",
    "tier": 1,
    "homepage": "https://www.mofcom.gov.cn",
    "country_code": "CN",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/ministry-of-commerce-of-china",
    "documents": [
      {
        "title": "上半年我国创新药对外技术授权交易额创新高",
        "url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 7
      },
      {
        "title": "2025年我国批准创新药76个 对外授权超千亿美元",
        "url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 23
      }
    ],
    "statistics": [
      {
        "id": "stat_H8FD1RAF0HRJDA674FRB5MNFWX",
        "url": "https://statorigin.org/stat/stat_H8FD1RAF0HRJDA674FRB5MNFWX",
        "indicator": {
          "slug": "approved-innovative-drugs-growth-rate",
          "name": "Approved innovative drugs growth rate",
          "definition": "Year-on-year percentage growth rate of innovative drugs approved for marketing."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 58.3,
        "value_text": "58.3%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "从国家药品监督管理局获悉，2025年我国创新药审评审批取得历史性突破，全年共批准上市创新药76个，较2024年的48个大幅增长58.3%，创历史新高；同时，数据显示，中国创新药对外授权（BD）交易总金额达1356.55亿美元，交易数量达157笔，双双刷新纪录。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_H8FD1RAF0HRJDA674FRB5MNFWX",
          "bibtex": "@misc{mofcom2025approved5mnfwx,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_H8FD1RAF0HRJDA674FRB5MNFWX},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_H0A44FGGE45T9X6BB14NAY01YN",
        "url": "https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN",
        "indicator": {
          "slug": "domestic-first-in-class-drug-approvals",
          "name": "Domestic first-in-class drug approvals",
          "definition": "Number of approved first-in-class drugs with novel mechanisms of action originated by domestic developers."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 4,
        "value_text": "4个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "根据国家药监局数据，2025年76个审批的创新药中，有11个是首创新药，但其中仅有4个是国内本土研发。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN",
          "bibtex": "@misc{mofcom2025domesticay01yn,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_TXCRG6H99JJA44HK338F298NKM",
        "url": "https://statorigin.org/stat/stat_TXCRG6H99JJA44HK338F298NKM",
        "indicator": {
          "slug": "domestic-innovative-biological-product-approvals",
          "name": "Domestic innovative biological product approvals",
          "definition": "Number of domestically originated innovative biological medicines granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 21,
        "value_text": "21个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_TXCRG6H99JJA44HK338F298NKM",
          "bibtex": "@misc{mofcom2025domestic298nkm,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_TXCRG6H99JJA44HK338F298NKM},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_Y05J4BZKQ3T9QTTA0N2TRGP56M",
        "url": "https://statorigin.org/stat/stat_Y05J4BZKQ3T9QTTA0N2TRGP56M",
        "indicator": {
          "slug": "domestic-innovative-chemical-drug-approvals",
          "name": "Domestic innovative chemical drug approvals",
          "definition": "Number of domestically originated innovative chemical drugs granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 38,
        "value_text": "38个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_Y05J4BZKQ3T9QTTA0N2TRGP56M",
          "bibtex": "@misc{mofcom2025domesticrgp56m,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_Y05J4BZKQ3T9QTTA0N2TRGP56M},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_DZHHYRNZK3VV28D8YKVZDC17P0",
        "url": "https://statorigin.org/stat/stat_DZHHYRNZK3VV28D8YKVZDC17P0",
        "indicator": {
          "slug": "domestic-innovative-drug-approvals-half-year",
          "name": "Domestic innovative drug approvals (half year)",
          "definition": "Total number of domestically developed innovative drugs approved for marketing within a specified period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 31,
        "value_text": "31款",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "工业和信息化部运行监测协调局局长陶青20日表示，今年上半年，我国创新药高质量成果不断涌现，38款创新药获批上市，其中国产创新药31款。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_DZHHYRNZK3VV28D8YKVZDC17P0",
          "bibtex": "@misc{mofcom2026domesticdc17p0,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_DZHHYRNZK3VV28D8YKVZDC17P0},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_HKV3JRNAGMYEMV9T44T3DRWMX8",
        "url": "https://statorigin.org/stat/stat_HKV3JRNAGMYEMV9T44T3DRWMX8",
        "indicator": {
          "slug": "domestic-share-of-approved-innovative-biological-products",
          "name": "Domestic share of approved innovative biological products",
          "definition": "Proportion of approved innovative biological medicines accounted for by domestic developers."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 91.3,
        "value_text": "91.30%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_HKV3JRNAGMYEMV9T44T3DRWMX8",
          "bibtex": "@misc{mofcom2025domesticdrwmx8,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_HKV3JRNAGMYEMV9T44T3DRWMX8},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_F85AT6C3FT96J2M4EQK79GG5F1",
        "url": "https://statorigin.org/stat/stat_F85AT6C3FT96J2M4EQK79GG5F1",
        "indicator": {
          "slug": "domestic-share-of-approved-innovative-chemical-drugs",
          "name": "Domestic share of approved innovative chemical drugs",
          "definition": "Proportion of approved innovative chemical medicines accounted for by domestic developers."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 80.85,
        "value_text": "80.85%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_F85AT6C3FT96J2M4EQK79GG5F1",
          "bibtex": "@misc{mofcom2025domestic9gg5f1,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_F85AT6C3FT96J2M4EQK79GG5F1},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW",
        "url": "https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW",
        "indicator": {
          "slug": "first-in-class-drug-approvals",
          "name": "First-in-class drug approvals",
          "definition": "Number of approved therapeutic drugs featuring a novel biological mechanism of action."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 11,
        "value_text": "11个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "根据国家药监局数据，2025年76个审批的创新药中，有11个是首创新药，但其中仅有4个是国内本土研发。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW",
          "bibtex": "@misc{mofcom2025firstnjaqfw,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_FV7KVH5AZZV7S3YXWSDJ9PYH4G",
        "url": "https://statorigin.org/stat/stat_FV7KVH5AZZV7S3YXWSDJ9PYH4G",
        "indicator": {
          "slug": "imported-innovative-biological-product-approvals",
          "name": "Imported innovative biological product approvals",
          "definition": "Number of imported innovative biological medicines granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 2,
        "value_text": "2个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_FV7KVH5AZZV7S3YXWSDJ9PYH4G",
          "bibtex": "@misc{mofcom2025imported9pyh4g,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_FV7KVH5AZZV7S3YXWSDJ9PYH4G},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_XF5THCP9E9X5K08BRF9JQKSKHZ",
        "url": "https://statorigin.org/stat/stat_XF5THCP9E9X5K08BRF9JQKSKHZ",
        "indicator": {
          "slug": "imported-innovative-chemical-drug-approvals",
          "name": "Imported innovative chemical drug approvals",
          "definition": "Number of imported innovative chemical drugs granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 9,
        "value_text": "9个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "47个化学药品中，38个为国产创新药，9个为进口创新药，国产创新药占比达80.85%；23个生物制品中，21个为国产创新药，2个为进口创新药，国产创新药占比达91.30%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_XF5THCP9E9X5K08BRF9JQKSKHZ",
          "bibtex": "@misc{mofcom2025importedqkskhz,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_XF5THCP9E9X5K08BRF9JQKSKHZ},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_5DG6G4WFB9Z5RNDG6599211W4E",
        "url": "https://statorigin.org/stat/stat_5DG6G4WFB9Z5RNDG6599211W4E",
        "indicator": {
          "slug": "innovative-biological-product-approvals",
          "name": "Innovative biological product approvals",
          "definition": "Total number of innovative biological medicines granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 23,
        "value_text": "23个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "2025年国家药监局批准上市的76个创新药包括47个化学药品、23个生物制品和6个中药。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_5DG6G4WFB9Z5RNDG6599211W4E",
          "bibtex": "@misc{mofcom2025innovative211w4e,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_5DG6G4WFB9Z5RNDG6599211W4E},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_5MDT6DECW5BZ1ESTFWTKSH5C6S",
        "url": "https://statorigin.org/stat/stat_5MDT6DECW5BZ1ESTFWTKSH5C6S",
        "indicator": {
          "slug": "innovative-chemical-drug-approvals",
          "name": "Innovative chemical drug approvals",
          "definition": "Total number of innovative small molecule chemical drugs granted regulatory marketing approval."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 47,
        "value_text": "47个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "2025年国家药监局批准上市的76个创新药包括47个化学药品、23个生物制品和6个中药。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_5MDT6DECW5BZ1ESTFWTKSH5C6S",
          "bibtex": "@misc{mofcom2025innovativesh5c6s,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_5MDT6DECW5BZ1ESTFWTKSH5C6S},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_3JREH297ZDCVFCAN73DVY57XD0",
        "url": "https://statorigin.org/stat/stat_3JREH297ZDCVFCAN73DVY57XD0",
        "indicator": {
          "slug": "innovative-drug-approvals",
          "name": "Innovative drug approvals",
          "definition": "Total number of innovative pharmaceutical products granted regulatory marketing authorization."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 76,
        "value_text": "76个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "从国家药品监督管理局获悉，2025年我国创新药审评审批取得历史性突破，全年共批准上市创新药76个，较2024年的48个大幅增长58.3%，创历史新高；同时，数据显示，中国创新药对外授权（BD）交易总金额达1356.55亿美元，交易数量达157笔，双双刷新纪录。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_3JREH297ZDCVFCAN73DVY57XD0",
          "bibtex": "@misc{mofcom2025innovativey57xd0,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_3JREH297ZDCVFCAN73DVY57XD0},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_3GQY919D4KAKWCR960KXP2VMDS",
        "url": "https://statorigin.org/stat/stat_3GQY919D4KAKWCR960KXP2VMDS",
        "indicator": {
          "slug": "innovative-drug-approvals",
          "name": "Innovative drug approvals",
          "definition": "Total number of innovative pharmaceutical products granted regulatory marketing authorization."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 48,
        "value_text": "48个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "从国家药品监督管理局获悉，2025年我国创新药审评审批取得历史性突破，全年共批准上市创新药76个，较2024年的48个大幅增长58.3%，创历史新高；同时，数据显示，中国创新药对外授权（BD）交易总金额达1356.55亿美元，交易数量达157笔，双双刷新纪录。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2024). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_3GQY919D4KAKWCR960KXP2VMDS",
          "bibtex": "@misc{mofcom2024innovativep2vmds,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_3GQY919D4KAKWCR960KXP2VMDS},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_NNK9RC6484FNE968YDPRXA3DBQ",
        "url": "https://statorigin.org/stat/stat_NNK9RC6484FNE968YDPRXA3DBQ",
        "indicator": {
          "slug": "innovative-drug-approvals-half-year",
          "name": "Innovative drug approvals (half year)",
          "definition": "Total number of innovative pharmaceutical products granted regulatory marketing authorization."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 38,
        "value_text": "38款",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "工业和信息化部运行监测协调局局长陶青20日表示，今年上半年，我国创新药高质量成果不断涌现，38款创新药获批上市，其中国产创新药31款。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_NNK9RC6484FNE968YDPRXA3DBQ",
          "bibtex": "@misc{mofcom2026innovativexa3dbq,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_NNK9RC6484FNE968YDPRXA3DBQ},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_VQB2T6XM8K37HKYY5FAA3RDS4B",
        "url": "https://statorigin.org/stat/stat_VQB2T6XM8K37HKYY5FAA3RDS4B",
        "indicator": {
          "slug": "innovative-drug-licensing-out-upfront-payment-value",
          "name": "Innovative drug licensing-out upfront payment value",
          "definition": "Cumulative total of upfront payments received from innovative drug out-licensing transactions during the specified period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 7,
        "value_text": "70亿美元",
        "unit": "USD",
        "currency": "USD",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "根据医药魔方NextPharma数据库数据，截至2025年12月31日，中国创新药全年对外授权交易总额达1356.55亿美元，首付款累计70亿美元，交易数量157笔，远超2024年全年的519亿美元和94笔。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": "stat_R6TMSVPSPD4Q4AZMKGEBJRGSAT",
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_VQB2T6XM8K37HKYY5FAA3RDS4B",
          "bibtex": "@misc{mofcom2025innovative3rds4b,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_VQB2T6XM8K37HKYY5FAA3RDS4B},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:54:55.327Z"
      },
      {
        "id": "stat_3YNE0Z7GVKRJWZ0KHEY2DHZX8X",
        "url": "https://statorigin.org/stat/stat_3YNE0Z7GVKRJWZ0KHEY2DHZX8X",
        "indicator": {
          "slug": "innovative-drug-out-licensing-deal-count",
          "name": "Innovative drug out-licensing deal count",
          "definition": "Total number of out-licensing transactions concluded for innovative pharmaceutical products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 157,
        "value_text": "157笔",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "从国家药品监督管理局获悉，2025年我国创新药审评审批取得历史性突破，全年共批准上市创新药76个，较2024年的48个大幅增长58.3%，创历史新高；同时，数据显示，中国创新药对外授权（BD）交易总金额达1356.55亿美元，交易数量达157笔，双双刷新纪录。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_3YNE0Z7GVKRJWZ0KHEY2DHZX8X",
          "bibtex": "@misc{mofcom2025innovativedhzx8x,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_3YNE0Z7GVKRJWZ0KHEY2DHZX8X},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_VNDV9W82X5CBC1TSHEWDHXEZ59",
        "url": "https://statorigin.org/stat/stat_VNDV9W82X5CBC1TSHEWDHXEZ59",
        "indicator": {
          "slug": "innovative-drug-out-licensing-deal-count",
          "name": "Innovative drug out-licensing deal count",
          "definition": "Total number of out-licensing transactions concluded for innovative pharmaceutical products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 94,
        "value_text": "94笔",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "根据医药魔方NextPharma数据库数据，截至2025年12月31日，中国创新药全年对外授权交易总额达1356.55亿美元，首付款累计70亿美元，交易数量157笔，远超2024年全年的519亿美元和94笔。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2024). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_VNDV9W82X5CBC1TSHEWDHXEZ59",
          "bibtex": "@misc{mofcom2024innovativehxez59,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_VNDV9W82X5CBC1TSHEWDHXEZ59},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_YAN9HAZBD87CE3RV0F0JJVYR5D",
        "url": "https://statorigin.org/stat/stat_YAN9HAZBD87CE3RV0F0JJVYR5D",
        "indicator": {
          "slug": "innovative-drug-out-licensing-deal-value",
          "name": "Innovative drug out-licensing deal value",
          "definition": "Total monetary value of out-licensing agreements signed for innovative pharmaceutical products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 135.655,
        "value_text": "1356.55亿美元",
        "unit": "USD",
        "currency": "USD",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "从国家药品监督管理局获悉，2025年我国创新药审评审批取得历史性突破，全年共批准上市创新药76个，较2024年的48个大幅增长58.3%，创历史新高；同时，数据显示，中国创新药对外授权（BD）交易总金额达1356.55亿美元，交易数量达157笔，双双刷新纪录。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": "stat_RKHVWMWY2JXB95059ZXB37SYS9",
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_YAN9HAZBD87CE3RV0F0JJVYR5D",
          "bibtex": "@misc{mofcom2025innovativejvyr5d,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YAN9HAZBD87CE3RV0F0JJVYR5D},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:54:55.327Z"
      },
      {
        "id": "stat_4Q866SFF5ANGQHW4KHJFB3AWPD",
        "url": "https://statorigin.org/stat/stat_4Q866SFF5ANGQHW4KHJFB3AWPD",
        "indicator": {
          "slug": "innovative-drug-out-licensing-deal-value",
          "name": "Innovative drug out-licensing deal value",
          "definition": "Total monetary value of out-licensing agreements signed for innovative pharmaceutical products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 51.9,
        "value_text": "519亿美元",
        "unit": "USD",
        "currency": "USD",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "根据医药魔方NextPharma数据库数据，截至2025年12月31日，中国创新药全年对外授权交易总额达1356.55亿美元，首付款累计70亿美元，交易数量157笔，远超2024年全年的519亿美元和94笔。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": "stat_18ZXEWPYG8DB7ZZW32GNJ6K351",
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2024). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_4Q866SFF5ANGQHW4KHJFB3AWPD",
          "bibtex": "@misc{mofcom2024innovativeb3awpd,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_4Q866SFF5ANGQHW4KHJFB3AWPD},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:54:55.327Z"
      },
      {
        "id": "stat_SGAHXS0HEMN2DEFHGBTDZFNMNM",
        "url": "https://statorigin.org/stat/stat_SGAHXS0HEMN2DEFHGBTDZFNMNM",
        "indicator": {
          "slug": "innovative-drug-out-licensing-deal-value-half-year",
          "name": "Innovative drug out-licensing deal value (half year)",
          "definition": "Total monetary value of out-licensing agreements signed for innovative pharmaceutical products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 100,
        "value_text": "超过1000亿美元",
        "unit": "USD",
        "currency": "USD",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "创新药对外技术授权再创新高，交易总额超过1000亿美元。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_SGAHXS0HEMN2DEFHGBTDZFNMNM",
          "bibtex": "@misc{mofcom2026innovativezfnmnm,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_SGAHXS0HEMN2DEFHGBTDZFNMNM},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_YPD8JE6C2844BKSMCM43051B06",
        "url": "https://statorigin.org/stat/stat_YPD8JE6C2844BKSMCM43051B06",
        "indicator": {
          "slug": "innovative-traditional-medicine-approvals",
          "name": "Innovative traditional medicine approvals",
          "definition": "Total number of innovative traditional medicines granted regulatory marketing authorization."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 6,
        "value_text": "6个",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "2025年国家药监局批准上市的76个创新药包括47个化学药品、23个生物制品和6个中药。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_YPD8JE6C2844BKSMCM43051B06",
          "bibtex": "@misc{mofcom2025innovative051b06,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YPD8JE6C2844BKSMCM43051B06},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_MVQ4MC164FMDKHQE951DTNTCR4",
        "url": "https://statorigin.org/stat/stat_MVQ4MC164FMDKHQE951DTNTCR4",
        "indicator": {
          "slug": "pharmaceutical-export-delivery-value-growth-half-year",
          "name": "Pharmaceutical export delivery value growth (half year)",
          "definition": "Year-on-year growth rate of pharmaceutical industry export delivery value."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 9,
        "value_text": "9%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "医药出口交货值超过2100亿元，同比增长9%，出口结构不断优化，化学制剂、生物制品等高附加值产品占比近20%，出口结构正从以原料药为主，向具有高附加值的制剂产品加速切换。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_MVQ4MC164FMDKHQE951DTNTCR4",
          "bibtex": "@misc{mofcom2026pharmaceuticaltntcr4,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_MVQ4MC164FMDKHQE951DTNTCR4},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_QXMKA0748Z42MVXHG8AR9F7NWH",
        "url": "https://statorigin.org/stat/stat_QXMKA0748Z42MVXHG8AR9F7NWH",
        "indicator": {
          "slug": "pharmaceutical-industry-export-delivery-value-half-year",
          "name": "Pharmaceutical industry export delivery value (half year)",
          "definition": "Total value of pharmaceutical industry products delivered for export."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 210,
        "value_text": "超过2100亿元",
        "unit": "CNY",
        "currency": "CNY",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "医药出口交货值超过2100亿元，同比增长9%，出口结构不断优化，化学制剂、生物制品等高附加值产品占比近20%，出口结构正从以原料药为主，向具有高附加值的制剂产品加速切换。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_QXMKA0748Z42MVXHG8AR9F7NWH",
          "bibtex": "@misc{mofcom2026pharmaceutical9f7nwh,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_QXMKA0748Z42MVXHG8AR9F7NWH},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_6DXT5R6ZJV8YR5542YE5YD4R82",
        "url": "https://statorigin.org/stat/stat_6DXT5R6ZJV8YR5542YE5YD4R82",
        "indicator": {
          "slug": "pharmaceutical-value-added-industrial-output-growth-half-year",
          "name": "Pharmaceutical value-added industrial output growth (half year)",
          "definition": "Year-on-year growth rate of value-added industrial output of major pharmaceutical manufacturing enterprises."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 6.4,
        "value_text": "6.4%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "1至6月，规模以上医药工业增加值同比增长6.4%，其中，生物制品增速达到两位数，成为驱动行业发展提速的主要引擎。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_6DXT5R6ZJV8YR5542YE5YD4R82",
          "bibtex": "@misc{mofcom2026pharmaceuticalyd4r82,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_6DXT5R6ZJV8YR5542YE5YD4R82},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_E5JN3DHT097E06Z20E6DXHZ5RG",
        "url": "https://statorigin.org/stat/stat_E5JN3DHT097E06Z20E6DXHZ5RG",
        "indicator": {
          "slug": "share-of-high-value-added-products-in-pharmaceutical-exports-half-year",
          "name": "Share of high-value-added products in pharmaceutical exports (half year)",
          "definition": "Proportion of high-value-added products such as chemical preparations and biological products in total pharmaceutical exports."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2026-01-01",
          "end": "2026-06-30",
          "type": "point"
        },
        "value": 20,
        "value_text": "近20%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "上半年我国创新药对外技术授权交易额创新高",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html",
          "document_type": "press_release",
          "locator": "上半年我国创新药对外技术授权交易额创新高",
          "quote": "医药出口交货值超过2100亿元，同比增长9%，出口结构不断优化，化学制剂、生物制品等高附加值产品占比近20%，出口结构正从以原料药为主，向具有高附加值的制剂产品加速切换。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2026). 上半年我国创新药对外技术授权交易额创新高. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Via StatOrigin, https://statorigin.org/stat/stat_E5JN3DHT097E06Z20E6DXHZ5RG",
          "bibtex": "@misc{mofcom2026sharexhz5rg,\n  author       = {{Ministry of Commerce of China}},\n  title        = {上半年我国创新药对外技术授权交易额创新高},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_E5JN3DHT097E06Z20E6DXHZ5RG},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/xwdt/bmdt/202607/200250.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_0WJ9J0GMFZWH3DVXFPR4VT4JDH",
        "url": "https://statorigin.org/stat/stat_0WJ9J0GMFZWH3DVXFPR4VT4JDH",
        "indicator": {
          "slug": "top-20-biological-targets-research-and-development-project-concentration",
          "name": "Top 20 biological targets research and development project concentration",
          "definition": "Proportion of total drug research and development pipeline projects concentrated in the top 20 most pursued biological targets."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CN",
          "name": "China",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 41,
        "value_text": "41%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Ministry of Commerce of China",
          "org_short_name": "MOFCOM",
          "org_url": "https://www.mofcom.gov.cn",
          "org_tier": 1,
          "document_title": "2025年我国批准创新药76个 对外授权超千亿美元",
          "document_url": "https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html",
          "document_type": "press_release",
          "locator": "2025年我国批准创新药76个 对外授权超千亿美元",
          "quote": "张玥坦言，目前我国创新药“扎堆研发”现象仍存，有数据显示，国内前20个热门靶点的研发项目集中度高达41%，而同期美国仅为28%。",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_0WJ9J0GMFZWH3DVXFPR4VT4JDH",
          "bibtex": "@misc{mofcom2025biologicalvt4jdh,\n  author       = {{Ministry of Commerce of China}},\n  title        = {2025年我国批准创新药76个 对外授权超千亿美元},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_0WJ9J0GMFZWH3DVXFPR4VT4JDH},\n  note         = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 27,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=ministry-of-commerce-of-china with a cursor to page through everything."
  }
}